香港醫思醫療集團(02138.HK)擬收購New Medical Center 51%股權
格隆匯5月18日丨香港醫思醫療集團(02138.HK)公佈,於2020年5月18日,公司、買方Jade Master International Limited(公司的間接全資附屬公司)、新控股公司、多名賣方與目標公司New Medical Center Limited訂立買賣協議,買方有條件同意促使新控股公司收購目標公司New Medical Center Limited的全部已發行股本,代價包括支付予賣方1億港元;與第一賣方及第五賣方兑換配發及發行新控股公司代價股份;向第一賣方配發及發行進一步代價股份;及向第一賣方支付不超過1600萬港元的或有對價,但須受買賣協議的條款及細則所規限。
於完成後,目標公司是新控股公司的全資附屬子公司,而新控股公司將由買方、第一賣方及第五賣方分別擁有 51%、48%及 1%權益。於完成後,預期目標公司的財務報表將綜合入賬集團。
公司表示,於本公告日期,目標公司擁有在香港醫務委員會的專科註冊中的13名全職註冊醫生。憑藉目標公司管理團隊的專業知識,公司認為目標公司業務的整合是對集團醫療範圍的補充。目標公司將可以定期轉介予集團內的實驗室和高端影像服務,從而進一步推動了集團的整體業務。為配合集團的擴展及加強集團於香港醫療服務的領導地位,董事認為收購事項將擴大集團高端醫療市場的市場份額。預期收購事項將改善集團應占業績及整體股東回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.